Literature DB >> 16699601

Schizophrenia: an integrative approach to modelling a complex disorder.

George S Robertson1, Sarah E Hori, Kelly J Powell.   

Abstract

The discovery of candidate susceptibility genes for schizophrenia and the generation of mice lacking proteins that reproduce biochemical processes that are disrupted in this mental illness offer unprecedented opportunities for improved modelling of this complex disorder. Several lines of evidence indicate that obstetrical complications, as well as fetal or neonatal exposure to viral infection, are predisposing events for some forms of schizophrenia. These environmental events can be modelled in animals, resulting in some of the characteristic features of schizophrenia; however, animal models have yet to be developed that encompass both environmental and genetic aspects of this mental illness. A large number of candidate schizophrenia susceptibility genes have been identified that encode proteins implicated in the regulation of synaptic plasticity, neurotransmission, neuronal migration, cell adherence, signal transduction, energy metabolism and neurite outgrowth. In support of the importance of these processes in schizophrenia, mice that have reduced levels or completely lack proteins that control glutamatergic neurotransmission, neuronal migration, cell adherence, signal transduction, neurite outgrowth and synaptic plasticity display many features reminiscent of schizophrenia. In the present review, we discuss strategies for modelling schizophrenia that involve treating mice that bear these mutations in a variety of ways to better model both environmental and genetic factors responsible for this complex mental illness according to a "two-hit hypothesis." Because rodents are able to perform complex cognitive tasks using odour but not visual or auditory cues, we hypothesize that olfactory-based tests of cognitive performance should be used to search for novel therapeutics that ameliorate the cognitive deficits that are a feature of this devastating mental disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16699601      PMCID: PMC1449879     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  180 in total

1.  Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia.

Authors:  L M Talamini; T Koch; G J Ter Horst; J Korf
Journal:  Brain Res       Date:  1998-04-13       Impact factor: 3.252

2.  Animal models of environmentally induced memory impairment.

Authors:  H L Evans; P J Bushnell; M J Pontecorvo; J D Taylor
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

3.  Influenza and schizophrenia. An analysis of post-influenzal "dementia precox," as of 1918, and five years later further studies of the psychiatric aspects of influenza. 1926.

Authors:  K A Menninger
Journal:  Am J Psychiatry       Date:  1994-06       Impact factor: 18.112

4.  Bacteriophage P1 site-specific recombination. III. Strand exchange during recombination at lox sites.

Authors:  N Sternberg
Journal:  J Mol Biol       Date:  1981-08-25       Impact factor: 5.469

Review 5.  Contribution of the neural cell adhesion molecule to neuronal and synaptic plasticity.

Authors:  J Z Kiss; D Muller
Journal:  Rev Neurosci       Date:  2001       Impact factor: 4.353

Review 6.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

Review 7.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

8.  Odor matching and odor memory in the rat.

Authors:  X C Lu; B M Slotnick; A M Silberberg
Journal:  Physiol Behav       Date:  1993-04

9.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  11 in total

1.  Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.

Authors:  Kosuke Kajitani; Michael Thorne; Michel Samson; George S Robertson
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

Review 2.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

Review 3.  Stem cell-based models and therapies: a key approach into schizophrenia treatment.

Authors:  Bagher Larijani; Peyvand Parhizkar Roudsari; Mahdieh Hadavandkhani; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Forough Azam Sayahpour; Fereshteh Mohamadi-Jahani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2021-01-02       Impact factor: 1.522

4.  Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine.

Authors:  Larissa de Oliveira; Daiane B Fraga; Renata D De Luca; Leila Canever; Fernando V Ghedim; Maria Paula P Matos; Emilio L Streck; João Quevedo; Alexandra I Zugno
Journal:  Metab Brain Dis       Date:  2011-02-18       Impact factor: 3.584

Review 5.  Role of cannabis and endocannabinoids in the genesis of schizophrenia.

Authors:  Emilio Fernandez-Espejo; Maria-Paz Viveros; Luis Núñez; Bart A Ellenbroek; Fernando Rodriguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2009-07-24       Impact factor: 4.530

6.  Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.

Authors:  René Gysin; Rudolf Kraftsik; Julie Sandell; Pierre Bovet; Céline Chappuis; Philippe Conus; Patricia Deppen; Martin Preisig; Viviane Ruiz; Pascal Steullet; Mirjana Tosic; Thomas Werge; Michel Cuénod; Kim Q Do
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-05       Impact factor: 11.205

Review 7.  A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia.

Authors:  Benjamin K Yee; Philipp Singer
Journal:  Cell Tissue Res       Date:  2013-04-12       Impact factor: 5.249

8.  Are NCAM deficient mice an animal model for schizophrenia?

Authors:  Anne Albrecht; Oliver Stork
Journal:  Front Behav Neurosci       Date:  2012-07-17       Impact factor: 3.558

9.  Loss of STOP protein impairs peripheral olfactory neurogenesis.

Authors:  Karelle Benardais; Basem Kasem; Alice Couegnas; Brigitte Samama; Sebastien Fernandez; Christiane Schaeffer; Maria-Cristina Antal; Didier Job; Annie Schweitzer; Annie Andrieux; Anne Giersch; Astrid Nehlig; Nelly Boehm
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

10.  A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes.

Authors:  Leila Canever; Larissa Oliveira; Renata D'Altoé de Luca; Paulo T F Correa; Daiane de B Fraga; Maria Paula Matos; Giselli Scaini; João Quevedo; Emílio L Streck; Alexandra I Zugno
Journal:  Oxid Med Cell Longev       Date:  2010-11-01       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.